Preimplantation Genetic Diagnosis Market 2024 Forecasts Research Report Now Available with OrbisResearch.com.

1. www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Preimplantation Genetic Diagnosis Market Analysis And
Segment Forecasts by 2024

2. www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Global preimplantation genetic diagnosisis market expected to reach USD 96.8 million by 2024,
according to a new report by Grand View Research, Inc. This expected growth in demand can be
ascribed to the growing incidence of inherited single gene associated and late onset genetic disorders.
Browse the report: http://www.orbisresearch.com/reports/index/preimplantation-genetic-diagnosis-
market-analysis-by-type-application-and-segment-forecasts-to-2024
Ongoing introduction of advancements in in-vitro fertilization (IVF) methods are key factors that have a
positive impact on the growth of this market. Incorporation of novel algorithms pertaining to genetic
diagnosis using NGS technology are expected to fuel demand in the coming years.
Demand for successful embryo implantation in couples who are detected with certain chromosomal
aberrations or fertility problems are also factors anticipated to boost growth in demand over the
forecast period.
Further key findings from the study suggest:
Chromosomal abnormalities accounted for over 36% of the revenue generated in 2015. This large share
can be attributed to growing usage of PGD techniques for detection of aneuploidies that are observed in
higher aged maternal patients. Furthermore, presence of large product portfolio of different market
players operating in chromosomal abnormality detection is responsible for large market share of this
technique.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/112789
Embryo HLA typing for stem cell therapy accounted for over 32% of the revenue generated in the
market for 2015. High incidence rate of single gene disorders and late onset hereditary oncology
diseases that need to be treated in order to curb the mortality rate are major driver for growth of this
segment.
Embryo implantation for treatment of the first child that is inherited with the chromosomal abnormality
by the virtue of ‘savior sibling’ is attributive towards market growth. With expected development of this
segment, the market will witness lucrative opportunities of growth over the forecast period.
North America dominated the market in 2015, with revenue estimated at over USD 35 million in 2015.
Presence of sophisticated healthcare infrastructure, rising aneuploidy, and infertility rates, favorable
government initiatives with respect to genetic diagnosis and its application in IVF are major factors
driving growth of this region.
Buy the report@ http://www.orbisresearch.com/contact/purchase/112789
Asia Pacific is expected to witness lucrative growth from 2016 to 2024 due to the availability of cost-
effective PGD procedures coupled with rapidly rising healthcare R&D investment, and growing medical
expenditures in emerging economies of India and China.

3. www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Key participants of the preimplantation genetic diagnosis market include Genesis Genetics, LabCorp,
Natera, Quest Diagnostics, Genea, Genzyme Corporation, Reproductive Genetics Institute, and F.
Hoffman La Roche Ltd.
These participants are involved in R&D for development of tests that can detect several chromosomal
abnormalities using single cell analysis and prevent inheritance of genetic imbalances.
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research
requirements. We have vast database of reports from the leading publishers and authors across
the globe. We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of
the industries and verticals of their specialization. This helps our clients to map their needs and
we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch